Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Plasminogen Activator Inhibitor-1 Protects Endothelial Cells from FasL-Mediated Apoptosis

Open access
Bajou, Khalid, Peng, Hongjun, Laug, Walter E., Maillard, Catherine, Noel, Agnes, Foidart, Jean M., Martial, Joseph A., DeClerck, Yves A.·2008·Cancer Cell

Abstract

SUMMARY Plasminogen activator inhibitor-1 (PAI-1) paradoxically enhances tumor progression and angiogenesis, however the mechanism supporting this role is not known. Here we provide evidence that PAI-1 is essential to protect endothelial cells (EC) from FasL-mediated apoptosis. In the absence of host-derived PAI-1, human neuroblastoma cells implanted in PAI-1 deficient mice form smaller and poorly vascularized tumors containing an increased number of apoptotic EC cells. We observed that knockdown of PAI-1 in EC enhances cell-associated plasmin activity, and increases spontaneous apoptosis in vitro. We further demonstrate that plasmin cleaves FasL at Arg144 - Lys145, releasing from the surface of EC a soluble pro-apoptotic FasL fragment. The data provide a mechanism explaining the pro-angiogenic activity of PAI-1. SIGNIFICANCE PAI-1, the central regulator of plasmin generation is a predictor of poor clinical outcome in cancer patients. We previously reported that PAI-1 has a pro-angiogenic function but the mechanism has remained poorly understood. Here we describe a mechanism for the pro-angiogenic function of PAI-1 by providing evidence that PAI-1 protects EC from Fas/FasL-mediated apoptosis. We demonstrate that in the absence of PAI-1 in EC, there is an increase in plasmin generation and the release by plasmin of a soluble FasL fragment. This plasmin-generated soluble FasL activates Fas and is a potent inducer of apoptosis in EC. Our results suggest that PAI-1 could be a target for anti-angiogenic and anti-vascular therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2008.08.012

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 161

Metadata

Authors
Bajou, K., Peng, H., Laug, W. E., Maillard, C., Noel, A., Foidart, J. M., Martial, J. A., & DeClerck, Y. A.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2008-10
Volume
14
Issue
4
Pages
324-334
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2119999444
Cited by
161
References
1
FWCI
2.02
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasminogen Activator Inhibitor-1 Protects Endothelial Cells from FasL-Mediated Apoptosis. https://app.cochat.ai/papers/10.1016/j.ccr.2008.08.012
The paper
Bajou, K., Peng, H., Laug, W. E., Maillard, C., Noel, A., Foidart, J. M., Martial, J. A., & DeClerck, Y. A. (2008). Plasminogen Activator Inhibitor-1 Protects Endothelial Cells from FasL-Mediated Apoptosis. Cancer Cell. https://doi.org/10.1016/j.ccr.2008.08.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.